Session Chairs: Richard Rogers, Umoja Biopharma and Sarah Rogstad, CDER, FDA
Session Description:
The future of our field is heavily dependent on innovative science from new and upcoming researchers. The Next Generation Investigator (NGI) session will showcase the cutting edge work of three very talented early career scientists. We look forward to learning what these next generation investigators have been working on to advance applications mass spectrometry.
Session Speakes:
Proteoform Specific Microheterogeneity Assessment of Biopharmaceuticals Using a Modified Orbitrap Tribrid Mass Spectrometer
Corentin Beaumal, NIBRT, National Institute for Bioprocessing Research
Middle-down Approach Using Proton Transfer Charge Reduction Enables Unambiguous Drug-Payload Localization in Cys-linked Antibody Drug Conjugates
Linda Lieu, University of Oklahoma
A Novel Mass Spectrometry-Based Footprinting Method for RNA Higher Order Structure
Natashia Yang, Washington University in St. Louis